TechFlow, Inc.

SpyCloud | September 24, 2020

SpyCloud, known for its unique breach data collection and curation platform that powers leading account takeover prevention and fraud investigation solutions, today announced its partnership with CyberDefenses, an award-winning Managed Security Services Provider (MSSP) and expert in election security, to protect the integrity of current and future elections. Across the United States, elections are operated by Secretary of State offices with more than 3,000 county governments forming the frontlin...

Government Business

DLT Solutions | November 19, 2020

DLT Solutions, LLC., a completely owned auxiliary of Tech Data and a head government technology solutions aggregator, has collaborated with Microsoft to bring to advertise Azure and Modern Workplace solutions to the U.S. public area. These contributions will be accessible through DLT's Cloud Navigator Program and will remember improved International Traffic for Arms Regulations (ITAR) agreeable help through DLT's Confirmed Stateside Support offering. As a result, DLT is an...

Government Business

Springbrook Software | November 09, 2021

Springbrook Software, the leading cloud-based ERP platform for local government agencies, just released advanced Capital Budgeting and Planning, fully integrated with Springbrook's cloud-based Cirrus financial platform. The solution reduces budget management and development time by 50%. "Our full featured solution is developed for government agency finance teams to help them track, measure and improve organizational performance. Customers have reported up to...

Pfizer | July 22, 2020

Pfizer Inc and German biotech firm BioNTech SE will get US$1.95 billion from the US government to produce and deliver 100 million doses of their Covid-19 vaccine candidate, the companies said on Wednesday. The agreement allows the US government to acquire an additional 500 million doses, the Department of Health and Human Services and the Department of Defense said. The Trump administration has agreed to spend billions of dollars for the development and procurement of a potential vaccine....